NIO Glioma Reveal
Diffuse Glioma (Brain Cancer)
CE Mark (EU); Research Use Only (US)Active
Key Facts
Indication
Diffuse Glioma (Brain Cancer)
Phase
CE Mark (EU); Research Use Only (US)
Status
Active
Company
About Invenio Imaging
Invenio Imaging is a private, commercial-stage company pioneering real-time intraoperative histology through its NIO Laser Imaging System, which leverages Stimulated Raman Histology (SRH) technology. The company has commercialized its core hardware system and has begun integrating artificial intelligence, evidenced by its CE-marked NIO Glioma Reveal algorithm for brain tumor surgery in the EU. Invenio targets multiple surgical subspecialties, including neurosurgery, pulmonology, and urology, with the goal of improving surgical decision-making and patient outcomes by providing rapid, on-site tissue analysis without destroying the sample.
View full company profile